Navigation Links
Watson's Anda Distribution to Build 234,000 sq ft Pharmaceutical Warehouse and Distribution Facility in Olive Branch, DeSoto County, MS
Date:8/11/2011

PARSIPPANY, N.J., Aug. 11, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its Anda Distribution division will construct a 234,000 square foot, state-of-the-art pharmaceutical distribution facility in Olive Branch, DeSoto County, MS.  The Company said the facility, which is expected to begin operation in the second quarter of 2012, will employ approximately 70 workers.  Anda officials credited the cooperation of the Mississippi Development Authority and Governor Haley Barbour's administration in its decision to invest approximately $23.5 million in the construction and outfitting of the Mississippi facility, and the relocation of operations from its current facility in Groveport, Ohio, to the state. IDI has been hired to construct the building at Crossroads Distribution Center, which is located just off Highway 78 in Olive Branch.

"We are very appreciative of the pro-business, pro-investment climate of Mississippi and Governor Barbour's administration, and of the welcome and support we have received from the state, DeSoto County and Olive Branch government and business leaders," said Albert Paonessa III, Executive Vice President and Chief Operating Officer of Anda Distribution.  "We are proud to join the number of companies that have located operations, or expanded current operations here, over the past several years.  We look forward to being a solid contributor to local employment, the local business community, and to enhancing our service to our national customers following our initiation of operations at the Olive Branch facility."

"Our new Olive Branch facility will enable Anda to maximize our proximity to and business relationship with Fed Ex, our current primary shipper," Paonessa continued.   "The new facility, as planned, will be more appropriately sized than our current leased facility in Ohio, resulting in significant efficiencies that will further streamline Anda's operations.  Finally, Mississippi was very supportive of our efforts to locate in the greater Memphis area, and to creating additional jobs to support the local economy."  

About AndaAnda Distribution is the fourth largest U.S. distributor of generic pharmaceuticals.  Anda primarily distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from more than 200 suppliers to more than 65,000 locations, including 11,000 physician accounts, 17,000 independent pharmacies, and more than 35,000 chain locations. Additionally, Anda sells to members of buying groups, which are independent pharmacies that join together to enhance their buying power.  Anda presently distributes products from facilities in Weston, Florida and Groveport, Ohio.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.  In 2010, Watson had global revenues, including Anda, of approximately $3.6 billion.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

About IDIIDI is a real estate company focused exclusively on industrial property. The company, headquartered in Atlanta, Georgia, provides development, investment and property management and leasing services supported by eight, strategically located U.S. market offices. Valued at $1.8 billion, IDI is among the largest privately-held logistics property companies in North America with ownership or interests in 33 million square feet of investment grade assets.

Since the company's founding in 1989, IDI has built a reputation for delivering superior quality properties and service. To date, IDI has developed and acquired 134 million square feet of industrial space and completed more than 500 industrial facilities in the U.S., Canada and Mexico. The company's investment portfolio, focused on building long-term value, holds more than 22 million square feet of assets and the company manages a portfolio of 50 million square feet.

Forward-Looking Statement Statements contained in this press release that refer to Watson's or Anda's estimated or anticipated financial results or other non-historical facts are forward-looking statements that reflect Watson's current perspective of existing trends and information as of the date of this release. For instance, any statements in this press release concerning prospects related to Watson's product launch timing, the date of opening the new distribution facility in Mississippi, and anticipated financial performance are forward-looking statements. It is important to note that Watson's goals and expectations are not predictions of actual performance. Watson's performance, at times, will differ from its goals and expectations. Actual results may differ materially from Watson's current expectations depending upon a number of factors affecting Watson's business. These factors include, among others, the difficulty of predicting the timing or outcome of U.S. Food and Drug Administration (FDA), U.S. Drug Enforcement Administration (DEA) or other federal, state or local regulatory agency inspections, approvals or actions; risks of  delays caused by unavailability of materials or labor, strikes or other factors outside of Watson's control; risks that the carrying values of assets may be negatively impacted by future events and circumstances; timely and successful consummation and implementation of strategic initiatives, including the construction and commencement of operations at the Mississippi distribution facility; successful compliance with FDA, DEA and other governmental regulations applicable to Watson's and its third party manufacturers' facilities, products and/or businesses; changes in generally accepted accounting principles; and such other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited to Watson's annual report on Form 10-K for the period ended December 31, 2010, and Watson's quarterly report on Form 10-Q for the period ended June 30, 2011. Except as expressly required by law, Watson disclaims any intent or obligation to update these forward-looking statements.

(Logo: http://photos.prnewswire.com/prnh/20100121/LA41294LOGO)CONTACTS:Investors:Patty Eisenhaur(862) 261-8141Media:Charlie Mayr(862) 261-8030
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
2. New Trial Presented at AAAAI Reports that the Growth of Children 2-5 Years Old with Year-Round Allergic Rhinitis Continued According to Normal Age-Adjusted Distribution Over a 6-Month Treatment with Nasacort AQ
3. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
4. Pulmo BioTech Inc. Completes Bio-Distribution Studies
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Optigenex Inc. Signs New License and Distribution Agreement With Itochu Corporation of Japan
7. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
8. RSB Spine, LLC, Announces Distribution Agreement with Paradigm BioDevices, Inc.
9. CVS Caremark Launches Distribution of $3 million in Free Seasonal Flu Shot Vouchers to the Unemployed
10. PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear, Nose, and Throat Market
11. Misonix Announces New Distribution Agreement for United Kingdom and Republic of Ireland
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... , ... June 24, 2016 , ... A recent ... most people are unfamiliar with. The article goes on to state that individuals are ... many of these less common operations such as calf and cheek reduction. The Los ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
Breaking Medicine News(10 mins):